Slabilax-Zdorovya oral drops 7.5 mg/ml bottle 30 ml

Composition of the medicinal product:
active ingredient: sodium picosulfate;
1 ml (15 drops) contains 7.5 mg of sodium picosulfate;
excipients: sodium benzoate (E 211), sorbitol (E 420), anhydrous citric acid, sodium citrate, purified water.
Dosage form.
Oral drops.

Clear solution from colorless to yellowish.
Name and location of the manufacturer.
LLC "Pharmaceutical Company" Zdorovya ".
Ukraine, 61013, Kharkiv, Shevchenko St., 22.

Pharmacotherapeutic group.
Contact laxatives. ATS code A06A B08.

Slabilax-Zdorovye is a contact laxative of the triarylmethane group of local action, which after bacterial cleavage in the colon stimulates its mucous membrane, enhances peristalsis of the colon, promotes the accumulation of water and electrolytes in the lumen of the colon. The result is stimulation of defecation, reduction of the transit period and softening of feces.
After oral administration, sodium picosulfate reaches the colon without significant absorption. Therefore, there is no intrahepatic circulation. By bacterial cleavage in the intestine, the active laxative component bis-(n-hydroxyphenyl)-pyridyl-2-methane (BHRM) is formed. The onset of action occurs within 6 to 12 hours, which is associated with the release of the active substance of the drug.
After oral administration, only a small amount of the drug can be detected in the organs and systems of the body.
The laxative effect of the drug is not related to the level of the active substance in the blood plasma.

Indications for use.

The ability to influence the reaction speed when driving or working with other mechanisms.
Does not affect.
Children.
The drug is prescribed to children after consultation with a doctor.
The drug is used in children from birth.
Method of administration and doses.
Recommended doses:
- adults and children over 10 years of age: 10-20 drops (5-10 mg);
- children from 4 to 10 years old: 5-10 drops (2.5-5 mg);
- for children from birth to 4 years: at the rate of 1 drop (0.5 mg) per 2 kg of body weight.
The drug must be taken at night so that bowel movements occur in the morning.
Overdose.
Symptoms: intestinal colic, diarrhea, disturbances of water and electrolyte balance (hypokalemia, loss of other electrolytes and fluid), muscle weakness.
Ischemia of the colonic mucosa has been reported with the use of large doses of the drug, which significantly exceed those usually recommended for constipation. Slabilax-Zdorovye, like other laxatives, with prolonged overdose leads to chronic diarrhea and abdominal pain, hypokalemia, secondary hyperaldosteronism and possible formation of kidney stones. With prolonged abuse of laxatives, there are reports of damage to the renal tubules, metabolic alkalosis, muscle weakness as a result of hypokalemia.
Treatment: drug withdrawal, gastric lavage, symptomatic therapy aimed at normalizing water and electrolyte balance and maintaining vital functions, antispasmodics if indicated.
Side effects.
Immune system disorders: hypersensitivity reactions, including angioedema, skin rash, urticaria, itching.
Gastrointestinal tract: abdominal cramps and pain, diarrhea, discomfort, dyspeptic phenomena.
Others: development of dehydration and electrolyte imbalance.
If any adverse reactions occur, stop using Pre-Parati and consult a doctor.
Interaction with other drugs and other types of interactions.
With simultaneous use with diuretics and glucocorticoids, the risk of water and electrolyte disturbances, in particular hypokalemia, increases. It is possible to reduce the tolerance of cardiac glycosides. Broad-spectrum antibiotics can reduce the weakening effect of sodium picosulfate.

Expiration date.
2 years.

Storage conditions.
Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.

Packaging.
Oral drops 7.5 mg/ml, 15 ml or 30 ml in a bottle in a box.

Vacation category.
Without a prescription.